416 related articles for article (PubMed ID: 17392396)
21. Predictive performance of three practical approaches for grapefruit juice-induced 2-fold or greater increases in AUC of concomitantly administered drugs.
Takahashi M; Onozawa S; Ogawa R; Uesawa Y; Echizen H
J Clin Pharm Ther; 2015 Feb; 40(1):91-7. PubMed ID: 25365914
[TBL] [Abstract][Full Text] [Related]
22. Grapefruit juice-lovastatin interaction.
Bailey DG; Dresser GK
Clin Pharmacol Ther; 2000 Jun; 67(6):690. PubMed ID: 10872652
[No Abstract] [Full Text] [Related]
23. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
Kaphalia BS; Mericle KA; Ansari GA
Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
[TBL] [Abstract][Full Text] [Related]
24. Grapefruit juice effects on the bioavailability of cyclosporin-A in rats.
Mangano NG; Cutuli VM; Caruso A; De Bernardis E; Amico-Roxas M
Eur Rev Med Pharmacol Sci; 2001; 5(1):1-6. PubMed ID: 11860217
[TBL] [Abstract][Full Text] [Related]
25. Transient inhibition of cyp3a in rats by star fruit juice.
Hidaka M; Okumura M; Ogikubo T; Kai H; Fujita K; Iwakiri T; Yamasaki K; Setoguchi N; Matsunaga N; Arimori K
Drug Metab Dispos; 2006 Mar; 34(3):343-5. PubMed ID: 16326816
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
Lau YY; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
[TBL] [Abstract][Full Text] [Related]
27. Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity.
Ohura K; Sakamoto H; Ninomiya S; Imai T
Drug Metab Dispos; 2010 Feb; 38(2):323-31. PubMed ID: 19923255
[TBL] [Abstract][Full Text] [Related]
28. Construction of a model to estimate the CYP3A inhibitory effect of grapefruit juice.
Uesawa Y; Abe M; Fukuda E; Baba M; Okada Y; Mohri K
Pharmazie; 2011 Jul; 66(7):525-8. PubMed ID: 21812328
[TBL] [Abstract][Full Text] [Related]
29. Effect of ciprofloxacin and grapefruit juice on oral pharmacokinetics of riluzole in Wistar rats.
Ravi PR; Vats R; Kora UR
J Pharm Pharmacol; 2013 Mar; 65(3):337-44. PubMed ID: 23356842
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
Takanaga H; Ohnishi A; Matsuo H; Sawada Y
Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
[TBL] [Abstract][Full Text] [Related]
31. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Agric Food Chem; 2008 Jun; 56(12):4840-5. PubMed ID: 18494494
[TBL] [Abstract][Full Text] [Related]
32. Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma.
Yoshigae Y; Imai T; Taketani M; Otagiri M
Chirality; 1999; 11(1):10-3. PubMed ID: 9914648
[TBL] [Abstract][Full Text] [Related]
33. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity.
Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y
Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159
[TBL] [Abstract][Full Text] [Related]
34. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles.
Strauch K; Lutz U; Bittner N; Lutz WK
Food Chem Toxicol; 2009 Aug; 47(8):1928-35. PubMed ID: 19445995
[TBL] [Abstract][Full Text] [Related]
35. Distribution of lovastatin to bone and its effect on bone turnover in rats.
Jadhav SB; Narayana Murthy PS; Singh MM; Jain GK
J Pharm Pharmacol; 2006 Nov; 58(11):1451-8. PubMed ID: 17132207
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of fruit juices on CYP3A activity.
Kim H; Yoon YJ; Shon JH; Cha IJ; Shin JG; Liu KH
Drug Metab Dispos; 2006 Apr; 34(4):521-3. PubMed ID: 16415112
[TBL] [Abstract][Full Text] [Related]
37. Effect of grapefruit juice in relation to human pharmacokinetic study.
Uno T; Yasui-Furukori N
Curr Clin Pharmacol; 2006 May; 1(2):157-61. PubMed ID: 18666368
[TBL] [Abstract][Full Text] [Related]
38. Publication bias on clinical studies of pharmacokinetic interactions between felodipine and grapefruit juice.
Uesawa Y; Takeuchi T; Mohri K
Pharmazie; 2010 May; 65(5):375-8. PubMed ID: 20503932
[TBL] [Abstract][Full Text] [Related]
39. Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein.
Shirasaka Y; Suzuki K; Nakanishi T; Tamai I
J Pharm Sci; 2011 Sep; 100(9):3843-53. PubMed ID: 21520088
[TBL] [Abstract][Full Text] [Related]
40. Drug interaction potentials among different brands of grapefruit juice.
Uesawa Y; Mohri K
Pharmazie; 2008 Feb; 63(2):144-6. PubMed ID: 18380401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
